Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × dupilumab × Clear all

NCT03886493 2021-10-15

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Prostatic Neoplasms